Viewing StudyNCT06015464



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2025-12-17 @ 7:22 AM
Study NCT ID: NCT06015464
Status: None
Last Update Posted: 2023-08-29 00:00:00
First Post: 2023-08-23 00:00:00

Brief Title: An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL
Sponsor:
Organization: The First Affiliated Hospital with Nanjing Medical University

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 81
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
98603
Who Masked List: